DGD Research - Leading the search for better health.
Current Research - Information on trials & testing
Study Opportunities - Learn how you can get involved
Healthy Living - Latest news on staying healthy
About DGD Research - Who we are and why we care

Publications & Abstracts

Publications

  • "Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults With Type 1 Diabetes." Satish K. Garg, MD¹, Sherwyn L. Schwartz, MD², Steven V. Edelman, MD³. Diabetes Care. Volume 27, Number 3, March 2004.
  • "Preference and Resource Utilization in Elderly Patients: Innolet® Versus Vial/Syringe." John Shelmet a*, Sherwyn L. Schwartzb, John Capplemanc, Gregory Petersond, Soren Skovlunde, Lene Lytzene, Lars Nicklassonf, John Liangf, William Lyness, Innolet® Study Group. 1. Available Online via ScienceDirect. November 13, 2003. A PDF. Diabetes Research And Clinical Practice
    www.elsevier.com/locate/diabres.
  • "Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral Drugs." Sherwyn Schwartz, M.D.; Richard Sievers, DO; Poul Strange, M.D, Ph.D.; William H. Lyness, Ph.D.; Priscilla Hollander, M.D.; For The *INS-2061 Study Team. Diabetes Care. Volume 26, Number 8, August 2003, pp: 2238-2243.
  • "AA2500 Testosterone Gel Normalizes Androgen Levels in Aging Males With Improvements in Body Composition and Sexual Function". C. Steidel, S. Schwartz, K. Jacoby, T. Sebree, T. Smith, R. Bachand and THE NORTH AMERICAN AA2500 T Gel STUDY GROUP. The Journal of Clinical Endocrinology & Metabolism. 88 (6) June 2003, pp:2673-2681.
  • "Nateglinide Well-Tolerated in Elderly Patients With Diabetes." Sherwyn L. Schwartz, M.D., Boris Draznin, M.D., Endocrine Today. Clinical News on Diabetes and Endocrine Disorders. (Volume pending). May 2003.
  • "Effects of an anti-CD5 Immunoconjugate (CD5-plus) in recent onset Type 1 Diabetes Mellitus: A Preliminary Investigation: The CD5 Diabetes Project Team." Skler JS, Lorenz TJ, Schwartz S, Eisenbarth GS, Einhorn D, Palmer JP, Marks JB, Greenbaum C, Saria EA, Byers V. Journal Diabetes Complications. Diabetes. Volume 52, May 2003, pp: 7.224-232.
  • "Recombinant Variant Of Ciliary Neurotrophic Factor For Weight Loss In Obese Adults. A randomized, Dose-Ranging Study." Mark P. Ettinger, M.D.; Thomas W. Littlejohn, M.D.; Sherwyn L. Schwartz, M.D.; Stuart R. Weiss, M.D.; Harris H. McIlwain, M.D.; Steven B. Heymsfield, M.D.; George A. Bray, M.D.; William G. Roberts, M.D.; Eugene R. Heyman, Ph.D.; Nancy Stambler, M.S.; Stanley Heshka, Ph.D.; Catherine Vicary, B.S.; Hans-Peter Guler, M.D. JAMA. April 9, 2003 - Volume 289, No. 14, pp3: 1826-1832.
  • "Importance of Early Insulin Secretion. Comparison of nateglinide and Glyburide in Previously Diet-Treated Patients With Type 2 Diabetes." Priscilla A. Hollander, M.D., Ph.D., Sherwyn L. Schwartz, M.D., Marjorie R. Gatlin, M.D. Stephen J. Haas, B.S., Hongjie Zheng, B.S., James S. Foley, Ph.D., Beth E. Dunning, Ph.D. Diabetes Care. 24:983-988, 2001.
  • "Sugar-Free Zinc Gluconate Glycine Lozenges (Cold Eeze®) Do Not Adversely Affect Glucose Control in Patients with Type 1 or Type 2 Diabetes Mellitus." Sherwyn L. Schwartz, M.D.; Jerome S. Fischer, M.D.; Mark S. Kipnes, M.D. American Journal Of Therapeutics. 1075-2765, 2001 Lippincott Willisms & Wilkins pp. 006-0611.
  • "Basal Insulin Therapy in Type 2 Diabetes: 28-week comparison of insulin Glargine (HOE 901) and NPH insulin." Julio Rosenstock, M.D. Sherwyn L. Schwartz, M.D., Charles M. Clark, Jr., M.D., Glen D. Park, Pharmd., David W. Donley, Ph.D., Mike B. Edwards, R.P.H. Diabetes Care. Volume 24, number 4, April 2001, pp. 631-636.
  • "Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy. A Randomized Controlled Trial." Stuart C. Apfel, M.D.; Sherwyn L. Schwartz, M.D.; Bruce T. Adornato, M.D.; Roy Freeman, M.D.; Victor Biton, M.D.; Marc Rendell, M.D.; Aaron Vinik, M.D.; Michael Giuliani, M.D.; J. Clarke Stevens, M.D.; Richard Barbano, M.D., Ph.D.; Peter J. Dyck, M.D.; for the rhNGF Clinical Investigator Group. Journal of the American Medical Association. November 1, 2000, Volume 284, Number 17, pp. 2215-2221.
  • "Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes Mellitus." S. Schwartz, P. Raskin, V. Fonseca, J. F. Graveline. The New England Journal of Medicine. Volume 338, Number 13,1998, pp. 861-866.
  • "Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus." Miroslav Backonja, M.D.; Ahmad Beydoun, M.D.; Keith R. Edwards, M.D.; Sherwyn L. Schwartz, M.D.; Vivian Fonseca, M.D.; Marykay Hes, B.S.; Linda LaMoreaux, M.P.H.; Elizabeth Garofalo, M.D.; for the Gabapentin Diabetic Neuropathy Study Group, The Journal of the American Medical Association. Volume 280, Number 21, 1998, pp. 1831-1836.
  • "Metformin: Co-Therapy with Sulfonylureas Improves Control in Non-Insulin-Dependent Diabetes Mellitus." Sherwyn L. Schwartz, M.D., Diabetes and Glandular Disease Research Center, San Antonio, Texas. Advances in Therapy®. Volume 14, No. 4, July/August 1997, pp. 209-212.
  • "Efficacy and Safety of Pravastatin in the Treatment of Patients with Type I or Type II Diabetes Mellitus and Hypercholesterolemia." Philip Raskin, MD, Om P. Ganda, MD, Sherwyn L. Schwartz, MD, David Willard, MD, Julio Rosenstock, MD, Peter A. Lodewick, MD, Bonnie Weiner, MD, Mark E. McGovern, MD, Jean M. Norton, MS, Gabriella G. Cucinotta, BS, Bruce D. Behounek, MD. The American Journal of Medicine. October 1995, Volume 99.
  • "Comparison of the Effects of Estrogen Alone and Estrogen Plus Androgen on Biochemical Markers of Bone Formation and Resorption in Postmenopausal Women." Raisz, Lawrence G.; Wilita, Brinda; Artis, Althea; Bowen, Angela; Schwartz, Sherwyn; Trachiotis, Margaret; and Smith, JoAnne: The Pharmaceuticals (B. W. , A.A.), The Middleton Foundation ( A.B.), and The Diabetes and Glandular Disease Clinic (S.S.) , 1995.
  • "Management of Diabetes Mellitus." Schwartz, Sherwyn, M.D. Essential Medical Information, Systems, Inc., Durant, Oklahoma, Third Edition, 1993.
  • "Effects of Short-Term Insulin Therapy Upon Therapeutic Response to Glipizide." Schwartz, Sherwyn L.; Fischer, Jerome S.; Kipnes, Mark S.; and Boyle, Mary. The American Journal of Medicine. (Supl 3A), September 18, 1987, p. 22-30.
  • "The Spectrum of Growth Abnormalities In Children With 18 q Deletions". Hale DE, Cody JD, Baillargeon J., Schaub R , Danney, MM, Leach RJ. Journal of Clinical Endocrinology and Metabolism 2000. 85:4450-4454.
  • "Treatment of Episodic Hyperammonemia in Children With Inborn Errors of Urea Synthesis." Brusilow SW, Danney, MM et al. New England Journal of Medicine. 310:1630, 1984.
  • "Integrated Concentration of Growth Hormone in Juvenile-Onset Diabetes." Hayford JT, Danney MM, Hendrix JA, Thompson RG. Diabetes. 29:391, 1980.
  • "Noninsulin-Dependent Diabetes Mellitus In Hispanic Youth (Type 2Y)." Danney MM. Diabetes. 47: pg. A82, 1998.
  • "Diabetes In Youth: It Is Not Just Type 1 Diabetes Anymore." Danney MM. The Texas Pediatric Society. September 1997.
  • "Growth Failure and Growth Hormone Deficiency in 18q-Syndrome." Danney MM. Pediatric Research. 37: 90A, 1995.
  • "Effects of Simvastatin on the Lipid Profile and Attainment of Low Density Lipoprotein Cholesterol Goals When Added to Thiazolidinedione Therapy in Patients with Type 2 Diabetes Mellitus: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial." Andrew J. Lewin, MD¹, Mark S. Kipnes, MD², Luigi F. Meneghini, MD³, Diane J. Plotkin, Inna T. Perevozskaya, PhD and , Yale B. Mitchel, MD , Darbie L. Maccubbin, PhD , Sukrut Shah, PhD, Jonathan A. Tolbert, MD, for the Simvastatin/Thiazolidinedione Study Group*. Clinical Therapeutics. Vol. 26, No. 3, 2004.
  • "Control of Postprandial Plasma Glucose by an Oral Insulin Product (HIM2) in Patients With Type 2 Diabetes." Mark S. Kipnes, MD¹; Paresh Dandona, MD²; Devjit Tripathy; MD²; J. Gordon Still, PhD³.; Gordana Kosutic, MD³. Diabetes Care. Volume 26, Number 2, February 2003, pp:421-426, 2003.
  • "Glycemic and Insulinemic Responses of Nondiabetic Healthy Adult Subjects to an Experimental Acid-Induced Viscosity Complex Incorporated Into a Glucose Beverage." Bryan W. Wolf, Ph.D., Chron-Si Lai, Ph.D., Mark S. Kipnes, M.D., Deborah G. Ataya, Ph.D., Keith B. Wheeler, Ph.D., Bradley A. Zinker, Ph.D., Keith A. Garleb, Ph.D., and Jeffrey L. Firkins, Ph.D. Nutrition. Volume 18, Numbers 7/8, ,2002 pp:621-626. ©Elsevier Science Inc., 2002.
  • "Use of Three Clinical Performance Guidelines to Evaluate Modified Glucose Strips." Mark S. Kipnes, M.D., Sawn M. Bina, M.D. Judy O Joynes, M.D., Ann Tideman, M.D. San Antonio, Texas. Diabetes, A Journal of the American Diabetes Association. June 14-18, 2002, Volume 51, Supplement 2.
  • "Long Term Effect of Glitazones in Clinical Practice." William F. Trigoso, M.D., Jacob Vadakekalam, M.D., Sherwyn L. Schwartz, M.D. Jerome S. Fischer, M.D., Mark S. Kipnes, M.D., Amna A. Salhin, M.D., Daina Dreimane, M.D. Litza Loza. San Antonio, Texas. Diabetes, A Journal of the American Diabetes Association. June 14-18, 2002, Volume 51, Supplement 2.
  • "Continuous Subcutaneous Infusion of Recombinant GLP-1 for 7 Days Dose Dependently Improved Glycemic Control in Type 2 Diabetes." Mario R. W. Ehlers, M.D., Roderick E. Harley, M.D., Roberta L. Schneider, M.D., Mark S. Kipnes, M.D.. Lincoln Nebraska; San Antonio, Texas. Diabetes, A Journal of the American Diabetes Association. June 14-18, 2002, Volume 51, Supplement 2.
  • "Which Patients Do Not Require a GH Stimulation Test for the Diagnosis of Adult GHH Deficiency?" Mark L. Hartman; Brenda J. Crowe; Beverly M. K. Biller; Ken K. Y. History of; David R. Clemmons and John J. Chipman, ON BEHALF OF THE HYPOCCS ADVISORY BOARD AND THE U.S. HYPOCCS STUDY GROUP*. Published in The Journal of Clinical Endocrinology & Metabolism. February 2002, Volume 87. No. 2. pp. 477-485.
  • "Effects of Losartan on Renal and Cardiovascular Outcomes In Patients With Type 2 Diabetes and Nephropathy." Barry M. Brenner, M.D.; Mark E. Cooper E. Cooper, M.D.; Dick De Zeeuw, M.D.; William F. Keane, M.D.; William E. Mitch, M.D.; Hans-Henrik Parving, M.D.; Guiseppe Remuzzi, M.D.; Steven M. Snapinn, Ph.D.; Zhonxin Zhang, Ph.D., and Shahnaz Shahinfar, M.D.; for the RENAAL Study Investigators*. Published in The New England Journal of Medicine. September 20, 2001, Volume 345, Number 12; pp. 861-868.
  • "Pioglitazone Hydrochloride in Combination with Sulfonylurea Therapy Improves Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Study." Mark S. Kipnes, et al., published in The American Journal of Medicine. July 2001, Volume 111, Number 1, published by Elsevier Science.
  • "Sugar-Free Zinc Gluconate Glycine Lozenges (Cold Eeze®) Do Not Adversely Affect Glucose Control in Patients with Type 1 or Type 2 Diabetes Mellitus." Sherwyn L. Schwartz, M.D.; Jerome S. Fischer, M.D.; Mark S. Kipnes, M.D. American Journal Of Therapeutics. 1075-2765 © 2001 Lippincott Willisms & Wilkins pp. 006-0611.
  • "Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis, A Randomized Controlled Trial." Steven T. Harris, M.D.; Nelson B. Watts, M.D.; Harry K. Genant, M.D.; Clark D. McKeever, M.D.; Thomas Hangartner, Ph.D.; Michael Keller, M.D.; Charles H. Chesnut III, M.D.; Jaques Brown, M.D.; Erik F. Eriksen, M.D.; Mohammed S. Hoseyni, Ph.D.; Douglas W. Axelrod, M.D., Ph.D. and Paul D. Miller, M.D. for the Vertebral Efficacy With Risedronate Therapy (VERT) Study Group*. The Journal of the American Medical Association. October 13, 1999, Volume 282, number 14, pp. 1344 - 1352.
  • "Glycemic Response To An Induced -Viscosity Complex Incorporated Into A Glucose Beverage In Healthy Adult Subjects". B.W. Wolf, C.-S. Lai, M. S. Kipnes, K. B. Wheeler and K. A. Garleb, MDs. The FASEB Journal. March 1998, Abstracts Part I, Volume 12, Number 4.
  • "Testosterone Pharmacokinetics after Application of an Investigational Transdermal System in Hypogonadal Men." Zhiling Yu, PhD, Suneel K. Gupta, PhD, Stephen s. Hwang, PhD, Mark S. Kipnes, MD, Arshag D. Mooradian, MD, Peter J. Snyder, MD. Journal Clinical Pharmacology. December 1997 Issue, www.accp1.org
  • "Management of Gestational Diabetes in the Obese Patient." Terri Ryan, RN, CDE; Jasso-Glavy, Carla, MS, RD, CDE; Kipnes, Mark S., M.D. and their health care team. Diabetes Spectrum. July/August 1995, Volume 8, Number 4, pp. 190 -191.
  • "Adverse Effects of Recombinant Human Insulin-Like Growth Factor I in Obese Insulin-Resistant Type II Diabetic Patients." Jabri, Nabeel, MD. ; Schalch, Don S., MD; Schwartz, Sherwyn L. , MD; Fischer, Jerome S., MD; Kipnes, Mark S., MD; Radnik, Barbara J., RN; Turman, Nancy J., MD; Marcisin , Victoria S., MD and Guler, Hans-Peter, MD. Diabetes, A Journal of the American Diabetes Association. March 1994, Volume 43.
  • "Effects of Short -Term Insulin Therapy upon Therapeutic Response to Glipizide." Schwartz, Sherwyn, MD; Fischer, Jerome S., MD; Kipnes, Mark S., MD and Boyle, Mary, RN., The American Journal of Medicine. September 18, 1987, Volume 83, Supplement 3A, pp. 22 - 30.
  • "Guidelines to Diabetes Management for the Primary Care Physician." Editorial Board, Professional Education Committee, American Diabetes Association Texas Affiliate, 1985.
return to top
home    current research    study opportunities    healthy living    about dgd research    contact    site map
Copyright © 2008.    dgd Research, Inc.   All rights reserved. web site design by monkee-boy | austin, texas